Enviva Inc.
EVA · NYSE
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $70 | $556 | $743 | $1,945 |
| - Cash | $177 | $315 | $2 | $5 |
| + Debt | $1,932 | $1,931 | $1,519 | $1,522 |
| Enterprise Value | $1,825 | $2,172 | $2,260 | $3,462 |
| Revenue | $313 | $321 | $302 | $269 |
| % Growth | -2.5% | 6.2% | 12.2% | – |
| Gross Profit | -$269 | $52 | $42 | -$19 |
| % Margin | -86.1% | 16.3% | 13.8% | -7% |
| EBITDA | -$319 | -$5 | $3 | -$18 |
| % Margin | -101.9% | -1.5% | 1% | -6.8% |
| Net Income | -$428 | -$85 | -$56 | -$117 |
| % Margin | -136.9% | -26.6% | -18.5% | -43.4% |
| EPS Diluted | -6.1 | -1.14 | -0.81 | -1.73 |
| % Growth | -435.1% | -40.7% | 53.2% | – |
| Operating Cash Flow | -$40 | -$55 | -$2 | $32 |
| Capital Expenditures | -$89 | -$76 | -$65 | -$72 |
| Free Cash Flow | -$129 | -$131 | -$67 | -$40 |